Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients
With Prostate Cancer That Has Been Removed by Surgery
Does Docetaxel help treat patients with prostate cancer that has been removed by surgery?
Basic Study Information
Purpose:Location: Highland Hospital
This randomized phase II/III trial studies docetaxel, antiandrogen therapy, and radiation
therapy to see how well it works compared with antiandrogen therapy and radiation
therapy alone in treating patients with prostate cancer that has been removed by surgery.
Androgen can cause the growth of prostate cells. Antihormone therapy may lessen the
amount of androgen made by the body. Radiation therapy uses high energy x-rays to
kill tumor cells and shrink tumors. Drugs used in chemotherapy, such as docetaxel,
work in different ways to stop the growth of tumor cells, either by killing the cells,
by stopping them from dividing, or by stopping them from spreading. Giving antiandrogen
therapy and radiation therapy with or without docetaxel after surgery may kill any
remaining tumor cells.
Lead Researcher (Principal Investigator)
Lead Researcher: Yuhchyau Chen
Study Contact InformationStudy Coordinator: Site Public Contact
Phone: (585) 341-8113
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search